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http://dx.doi.org/10.1016/j.jmii.2013Background: Prosthetic joint infection (PJI) after total knee or hip replacement is a devas-
tating complication associated with substantial morbidity and economic cost. The incidence
of prosthetic joint infection is increasing as the use of mechanical joint replacement increases.
The treatment approach to prosthetic joint infection is based on different clinical situations
such as a patient’s comorbidities, epidemic microbiology data, and surgical procedures. The
aim of our study was to understand clinical characteristics of prosthetic joint infection, the
microbiology of the prosthetic joint infection, and the outcomes of different treatment stra-
tegies during 2006e2011.
Methods: We retrospectively collected cases of prosthetic joint infection in the National
Taiwan University Hospital between January 1, 2006 and December 31, 2011. The patients’
characteristics, microbiology, outcomes, and factors associated with treatment success were
recorded.
Results: One hundred and forty-four patients were identified as having PJI. Of these, 92 pa-
tients were entered into per-protocol analysis. Staphylococcus aureus was the most common
causative organism (29.9%), followed by coagulase-negative Staphylococci (16.7%), and
Enterococci (9.7%). The overall treatment success rate was 50%. Patients who received a
two-stage revision had a better outcome, compared to patients who underwent other types
of surgeries (70% vs. 32.7%, respectively; p < 0.001). In multivariate analysis, the two-stageof Internal Medicine, National Taiwan University Hospital and National Taiwan University, Number 7,
District, Taipei City 10002, Taiwan.
.tw (W.-H. Sheng).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
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Prosthetic joint infection in Taiwan 199revision was significantly associated with treatment success (odds ratio Z 3.923, 95% confi-
dence interval Z 1.53e10.04).
Conclusion: Our study demonstrates that Staphylococcus aureus was the most common causa-
tive organisms in PJI. Performing two-stage revisions was significantly associated with a better
outcome.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Because of changing lifestyles and prolonged longevity,
there is an increasing prevalence of osteoarthritis among
the elderly.1 The symptoms of osteoarthritis affect a pa-
tient’s normal activity and may reduce a person’s function.
Arthroplasty improves a patient’s quality of life and is
highly cost effective.2,3 However, prosthetic joint infection
(PJI) after total knee or hip replacement is a devastating
complication associated with substantial morbidity and
economic cost.4 The frequency of PJI is increasing as the
use of mechanical joint replacement increases. The inci-
dence of PJI of these arthroplasties is between 1% and 2%.5
Management of infection in arthroplasty poses the chal-
lenge of eradicating the infection. The two-stage revision is
the most common approach to PJI in many countries.6,7 A
recent meta-analysis includingd926 two-stage knee joint
revisionsdreport an 82%e100% success rate.8 The treat-
ment success rates described for two-stage revisions for hip
prostheses ranges from 75% to 90%.9e12 However, the
approach to management is based on different clinical
situations, a patient’s comorbidities, and surgical risks.13 In
this study, we analyzed the clinical characteristics, micro-
biology, and the outcomes of different treatment strategies
for PJI in a medical center during 2006e2011.Materials and methods
Study design
This was a retrospective chart review of all cases of PJI in
the National Taiwan University Hospital between January 1,
2006 and December 31, 2011. The study was approved by
the ethics committee of NTUH.
By using hospital activity coding databases (Interna-
tional Classification of Diseases-edition 9; code 996.66)14
Patients were managed by infectious disease physicians
and orthopedic surgeons in a multidisciplinary team. We
included all patients with PJI. PJI was defined as the clin-
ical syndrome of arthroplasty infection (i.e., any persistent
inflammation in the tissues around the implant, wound
discharge, or implant loosening) with one or more of the
following: bacterial growth of an indistinguishable organism
from two or more deep periprosthetic tissue samples; his-
tology of the periprosthetic tissues indicative of infection;
or a persistent sinus tract.15 Excluded from analysis were
patients who were <20 years old, who experienced an open
reduction with internal fixation (ORIF) infection, or who
had missing data after reviewing the charts.Definitions
We defined treatment success as a patient being free of
symptoms and discontinuing antibiotics after the manage-
ment of a PJI for more than 1 year. Treatment failure was
defined as one of the following: (1) the recurrence of the
same PJI because of the original microorganism at any time
after the first intervention (i.e., relapse of infection); (2)
the recurrence of the same PJI because of a different strain
of a microorganism or a different microorganism (i.e.,
reinfection) at any time after the first intervention; (3) the
presence of an acute inflammation in the periprosthetic
tissue on histopathological examination or at any subse-
quent surgery on the joint; (4) the development of a sinus
tract to the joint; or (5) death from PJI. A PJI-related death
was defined as death directly caused by sepsis due to active
PJI symptoms and without other infection focus detected
by an infectious disease specialist.16 Recurrent infection
(relapse and reinfection) or persistent infection was
defined as swelling and pain of the joint or sinus tract
drainage, elevated C-reactive protein (CRP), persistent
positive culture after interventions during follow-up ex-
aminations at the clinic. Patients who were followed up for
at least 1 year were included in the per-protocol analysis
(Fig. 1). Prosthetic joint infection has been characterized
as “early” (i.e., developing within the first 3 months after
surgery), “delayed” (i.e., occurring 3e24 months after
surgery), and “late” (i.e., occurring >24 months after
surgery).17
Data collection
From the medical records, we collected data on patient
demographics, comorbidities (e.g., diabetes, chronic kid-
ney disease, liver disease, hypertension, chronic lung dis-
ease, rheumatoid arthritis, and malignancy), the site of
arthroplasty, date of surgical intervention, different in-
terventions (e.g., debridement and retention of prosthesis,
debridement with removal of the implant, one-stage revi-
sion, two-stage revision, and medical treatment only),
antibiotic treatment duration, and microbiology data (ob-
tained from synovial fluid culture, deep tissue culture, and
blood culture).18
Statistical analysis
All statistical hypothesis testing was assessed with 0.05
level of significance. The outcome was analyzed by using
the Chi-square test or the Fisher’s exact test. Descriptive
Excluded
Patients from coding
databases
(n = 170)
(n = 144)
(n = 92)
Patients with
prosthetic joint
infection
Patients of per-
protocol analysis
5. Age < 20 year-old, (n = 2)
6. ORIF infection, (n = 3)
7. Wound infection, (n = 15)
8. Missing data, (n = 6)
Excluded loss to follow-up, 
(n = 52)
Figure 1. Diagram of patients with infected prosthetic joint,
based on per-protocol analysis.
200 J.-C. Tsai et al.statistics such as the mean, standard deviation, and 95%
confidence interval was used for the continuous variables.
Categorical variables were summarized by counts and per-
centage in the frequency table. Variables in the univariate
analysis with p < 0.2 were entered in the multivariate
analysis by using the multiple logistic regression method.
The data were censored from follow-up after the infection
recurred or when the patient was lost to follow-up. All
statistical analyses were performed by using the software
SPSS version 17.0 (SPSS Inc., Chicago, IL, USA).Results
Demographic characteristics
One hundred and forty-four patients were included in the
study. The mean age was 68 years (standard deviation, 13.1
years). There were 81 (56.2%) female patients. The knee
was the most commonly infected site (61.1%). Half (56.9%)
of the patients had hypertension, 34% of the patients had
diabetes, 11.1% of the patients had chronic lung disease,
11.8% of the patients had liver disease, and 13.9% of the
patients had chronic kidney disease. In addition, 6.3% of
the patients had a malignancy and 5.6% of the patients had
rheumatic arthritis. One hundred and sixteen (80.6%) pa-
tients had primary revision prosthesis and 28 (19.4%) pa-
tients had a secondary revision prosthesis. Most (59.02 %)
patients had a late prosthesis joint infection (i.e., the time
since the first prosthesis joint infection was >1 year), fol-
lowed by 18.8% of patients with delayed PJI, and 19.4% of
patients with early PJI. Fifty-eight (40.3%) patients
received a two-stage revision. A total of 33.3% patients did
not receive antibiotics after reimplantation during follow-up. The median duration of intravenous or oral antibiotic
use after reimplantation was 6.1 weeks (range, 1e114
weeks; Table 1).
Microbiology results
The causative pathogens included Gram-positive cocci,
(64.6%), Gram-negative bacilli (21.5%), Candida species
(0.7%), and Mycobacterium tuberculosis (0.7%). The most
common causative organisms were Staphylococcus aureus
(29.9%), coagulase-negative staphylococci (16.7%), and
enterococci (9.7%). The rate of culture negative infection
was 18.8%. Concomitant positive blood culture was 7.6%
(Table 2). S. aureus was cultured less frequently from the
knee joint than from non-knee joints (23.9% vs. 39.3%,
p Z 0.049). However, this microorganism was not associ-
ated with primary or secondary revision prosthesis.
Outcomes
In the per-protocol analysis, 46 (50%) patients were treated
successfully. Only patients who received the two-stage
revision surgery had a better treatment outcome [65.2%
(success) vs. 28.3% (failure); p < 0.001]. Patients who
received debridement while retaining the implant had a
higher treatment failure rate [13% (success) vs. 41.3%
(failure); p Z 0.002]. There was no significant differences
in age, sex, comorbidities, steroid or immunosuppressive
therapy, prosthetic location, type of prosthesis, or other
infective organisms (Table 3). There was no difference in
the treatment failure group with or without methicillin-
resistant Staphylococcus aureus (MRSA; p Z 0.536). Posi-
tive blood culture was 15.2% in the treatment failure group
and 4.3% in the treatment success group; however, there
was no significant difference (p Z 0.207). The mean age
tended to be older in the nonetwo-stage revision group
(71.4 years) than in the two-stage revision group (67.9
years); however, there was no significant difference
(p Z 0.081).
The two-stage revision group most frequently had a
primary type prosthesis, but the nonetwo-stage group
more frequently had the secondary type prosthesis.
Twenty-nine (51.7%) patients needed repeated debride-
ment and were predominantly in the debridement with
retention of prosthesis group. Only 3 (10.3%) patients in the
medical treatment group received repeated debridement.
However, all positive blood cultures were in the nonetwo-
stage revision group (18.4%). There was no positive blood
culture in the two-stage revision group (0%; p Z 0.008;
Table 4).
On multivariate analysis, only the two-stage revision was
significantly associated with treatment success [odds ratio
(OR) Z 3.923, 95% confidence interval (CI): 1.53e10.04;
Table 5]. On follow-up at 2 years, 34 patients had experi-
enced a recurrent infection. Of these patients, 9 (26.5%)
patients in the two-stage revision group and 25 (73.5%)
patients developed a recurrent infection (p Z 0.036). The
Kaplan-Meier plot also demonstrated a recurrent infection
rate of PJI over time, which was significantly increased in
the nonetwo-stage revision group during follow-up in our
study period (p Z 0.003; Fig. 2).
Table 2 The microbiology of prosthetic joint infection
N (%)
Aerobic Gram-positive
Staphylococcus aureus 43 (29.9)
MSSA 28 (19.4)
MRSA 15 (10.4)
Coagulase-negative staphylococci 24 (16.7)
Streptococci 12 (8.3)
Enterococci 14 (9.7)
Aerobic Gram-negative
Escherichia coli 4 (2.8)
Klebsiella pneumoniae 3 (2.1)
Pseudomonas aereginosa 8 (5.6)
Acinetobacter baumannii 6 (4.2)
Enterobacter cloacae 2 (1.4)
Serrratia marcescens 3 (2.1)
Other Gram-negative bacilli 5 (1.7)
Polymicrobial infection 16 (11.1)
Candida spp. 1 (0.7)
Mycobacterium tuberculosis 1 (0.7)
Culture negative 27 (18.8)
Concomitant positive blood culture
MRSA 3 (27)
MSSA 3 (27)
Escherichia coli 2 (18.2)
Samonella choleraesuis 1 (9.1)
Aeromonas sorbia 1 (9.1)
Streptococcus gordonii 1 (9.1)
MRSA Z methicillin-resistant Staphylococcus aureus;
MSSA Z methicillin-sensitive Staphylococcus aureus.
Table 1 Demographic features of 144 patients with
prosthetic joint infection
Demographic characteristics N Z 144 %
Age, mean (SD) 68.9 (13.1)
Sex
Male 63 43.8
Female 81 56.2
Joint
Hip 52 36.1
Knee 88 61.1
Elbow 4 2.8
Comorbidities
Diabetes 49 34
Hypertension 82 56.9
Chronic lung disease 16 11.1
Liver disease 17 11.8
Chronic kidney disease 20 13.9
Malignancy 9 6.3
Rheumatic arthritis 8 5.6
Immunosuppressive therapy
or steroid use
9 6.3
Prosthesis
Primary 116 80.6
Secondary 28 19.4
Time from first prosthesis joint replacement to
prosthetic joint infectiona
Early (3 mo) 28 19.4
Delayed (>3 mo to 1 y) 27 18.8
Late (>1 y) 85 59
Missing data 4 2.8
Procedure
Debridement with retention
of the prosthesis
35 24.3
Debridement with removal
of the implant
25 17.4
One-stage revision 2 1.4
Two-stage revision 58 40.3
Medical treatment only 24 16.7
Gap between the two stages
<2 mo 23 39.7
2e4 mo 21 36.2
>4e12 mo 11 19
>1e2 y 2 3.5
>2 y 1 1.7
Outcome
Success 46 31.9
Failure 98 68.1
Antibiotic treatment duration after
reimplantation (1 and 2 stage)b
None 19 33.3
<1 wk 0 0
1e<6 wk 15 26.3
6 wke<6 mo 14 24.6
6 moe<1 y 8 14
1 y 1 1.8
a The time interval is described as the first time of prosthetic
joint replacement to the onset of prosthetic joint infection.
b The antibiotic treatment duration is calculated as the time
after discharge.
SD Z standard deviation.
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To our knowledge, our study is one of several large case
series of PJI in the medical literature.15,19e21 Our results
agree with another report that the two-stage revision
resulted in a better outcome in PJI.19 In Taiwan, the most
common causative organism of PJI is S. aureus. Staphylo-
cocci account for nearly half of PJI cases. This finding is
similar to the finding of a study by Trampuz et al.20 How-
ever, Bejon et al15 reported coagulase-negative staphylo-
cocci as the most commonly isolated organism in their
study. Different studies have different culture negative
rate. In the current study, the culture negative rate was
18.8% and often in the context of previous antimicrobial
therapy. Bejon et al15 report a surprisingly high culture
negative rate of 41%. However, only a 7% culture negative
rate was noted in a study by Berbari et al.21 Prosthetic joint
infection by Candida and Mycobacterium were noted in our
respective review of one patient. Fungal cultures, myco-
bacterial cultures, or both may be considered (e.g., if
bacterial cultures are negative in a patient with an
apparent infection).22 Similar to findings of a previous
report,23 we found that fungi or Mycobacterium were un-
common pathogens. Concomitant positive blood cultures
were identified in 11 patients. There was no difference
between the treatment success and failure group.
There was no significant difference in demographic
characteristics or microbiology between the treatment
Table 3 Factors associated with treatment outcome by per-protocol analysis
Factors Outcome
Success (n Z 46) Failure (n Z 46) p
Age, mean (SD) 69.4 (15.2) 70.1 (10.9) 0.571
Sex
Male 19 (41.3) 21 (45.7) 0.674
Comorbidities
Diabetes 14 (30.4) 16 (34.8) 0.656
Liver disease 5 (10.9) 7 (15.2) 0.536
Chronic kidney disease 7 (15.2) 6 (13) 0.765
Hypertension 32 (69.6) 25 (54.3) 0.133
Chronic lung disease 6 (13) 4 (8.7) 0.503
Malignancy 0 (0) 3 (6.5) 0.242
Rheumatic arthritis 3 (6.5) 4 (8.7) 0.694
Immunosuppressive therapy or steroid use 4 (8.7) 3 (6.5) 0.694
Prosthesis location
Hip 14 (45.7) 16 (34.8) 0.656
Non-hip 32 (69.6) 30 (65.2)
Type of prosthesis
Primary 40 (87) 34 (73.9) 0.115
Secondary 6 (13) 12 (26.1)
Procedure
One stage revision 1 (2.2) 0 (0) 0.315
Two-stage revision 30 (65.2) 13 (28.3) <0.001
Debridement with implant retention 6 (13) 19 (41.3) 0.002
Debridement with removal of implant 3 (6.5) 7 (15.2) 0.108
Medical treatment only 6 (13) 7 (15.2) 0.765
Microbiology
MRSA 5 (10.9) 7 (15.2) 0.536
MSSA 10 (21.7) 11 (23.9) 0.804
Coagulase-negative Staphylococcus 9 (19.6) 9 (19.6) > 0.99
Enterococci 6 (13) 4 (8.7) 0.503
Streptococci 3 (6.5) 5 (10.9) 0.694
Gram-negative bacilli 7 (15.2) 11 (23.9) 0.293
Culture negative 8 (17.4) 5 (10.9) 0.369
Positive blood culture 2 (4.3) 7 (15.2) 0.207
Data are presented as n (%) unless otherwise indicated.
MRSA Z methicillin-resistant Staphylococcus aureus; MSSA Z methicillin-sensitive Staphylococcus aureus; SD Z standard deviation.
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vention by two-stage revision (Table 2). The two-stage
revision was associated with a better outcome, compared
to other interventions. Positive blood cultures were all
isolated from the non-two-stage revision group. On multi-
variate analysis, however, a positive blood culture was not
an independent factor for the treatment outcome. We
revealed that the two-stage revision was the only factor
that successfully eradicated PJI. Haleem et al24 report that
the success of the two-stage reimplantation of an infected
total knee arthroplasty is well maintained and with a
modest rate of late recurrent infection (9%) or mechanical
implant failure (6%).
Wilson et al25 showed that the risk of PJI is significantly
increased in patientsdparticularly in malesdwho had
rheumatoid arthritis, ulcers of the skin, and who had un-
dergone a previous operation on the knee. However, our
study did not show these risk factors. Zimmerli et al26
showed that another important risk of PJI was undergoingrevision of an existing prosthetic joint. However, most of
our patients with PJI had a primary prosthesis revision. In
our study, the distribution of time since the first prosthesis
joint infection was predominantly the late PJI infection.
Bejon et al15 showed that 83% of the patients had a late PJI
infection. In the two-stage revision, giving empirical sys-
temic antibiotics after the first-stage operation while
awaiting culture results was more widely accepted.13
However, most of these patients did receive further anti-
biotics because of positive microbiological sampling of the
joint space at the second stage.15 The finding was similar in
our study in that half of the patients received antibiotics
within 6 months after reimplantations.
We found that patients who received the two-stage
revision had better outcomes, based on univariate analysis
or multivariate analysis. In several studies, there is a high
failure rate in other interventions such as debridement with
the retention of the prosthesis, debridement with removal
of prosthesis, and the one-stage revision.27e29 Our study
Table 4 Characteristics of the two-stage revision and the non-two-stage revision by per-protocol analysis
Two-stage revision
(n Z 43)
Non-two-stage revision
(n Z 49)
p
Success rate 30 (70) 16 (32.7) <0.001
Age, y (SD) 67.9 (12.9) 71.4 (13.4) 0.081
Sex
Male 23 (53.5) 17 (34.7) 0.07
Comorbidities
Diabetes 15 (34.9) 15 (30.6) 0.663
Liver disease 5 (11.6) 7 (14.3) 0.706
Chronic kidney disease 7 (16.3) 6 (12.2) 0.579
Hypertension 28 (65.1) 29 (59.2) 0.559
Pulmonary disease 3 (7) 7 (14.3) 0.261
Malignancy 1 (2.3) 2 (4.1) 0.636
Rheumatic arthritis 4 (9.3) 3 (6.1) 0.566
Prosthesis location
Hip 12 (28) 18 (36.7) 0.367
Non-hip 31 (72) 31 (63.3)
Type of prosthesis
Primary 38 (88.4) 36 (73.5) 0.072
Secondary 5 (11.6) 13 (26.5)
Microbiology
MRSA 5 (11.6) 7 (14.3) 0.706
MSSA 9 (20.9) 12 (24.5) 0.685
Gram-negative bacilli 7 (16.3) 11 (22.4) 0.457
Positive blood culture 0 (0) 9 (18.4) 0.008
Data are presented as n (%) unless otherwise indicated.
MRSA Z methicillin-resistant Staphylococcus aureus; MSSA Z methicillin-sensitive Staphylococcus aureus; SD Z standard deviation.
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recurrent infection was less developed in patients who
received the two-stage revision.
Our study had several limitations. First, this was a
retrospective case collection; therefore, collection bias
may have occurred. However, our results showed no sig-
nificant differences in the basic demographic characteris-
tics between the treatment success and treatment failure
groups. Second, we excluded 52 patients whose follow-up
was <1 year or who were lost to follow-up during the study
period. For this reason, the power of our study was limited
by the relative small case number. Third, important pa-
rameters such as debridement delay (i.e., the time from
the onset of symptoms to debridement) and CRP level or
the white blood cell count at the diagnosis of PJI were not
analyzed in our study. Approximately 19.1 % patients who
were diagnosed as having PJI were transferred from other
hospitals with partial treatment. The definite laboratoryTable 5 Factors associated with treatment success, using
the multivariate Cox regression
Factors OR 95% CI p
Type of prosthesis
(secondary revision)
0.513 0.158e1.666 0.267
Two-stage revision 3.923 1.532e10.042 0.004
Positive blood culture 0.446 0.075e2.668 0.376
CI Z confidence interval; OR Z odds ratio.data and debridement delay could not be calculated
correctly.
In conclusion, the most common infective organisms
were staphylococci. The two-stage revision was associated
with a better outcome and it was also an independentFigure 2. The Kaplan-Meier plot shows the cumulative
recurrent infection rate, based on treatment.
204 J.-C. Tsai et al.factor in the multivariate analysis. Positive blood cultures
were all found in the patients who had undergone the non-
two-stage revision; however, this did not affect the treat-
ment outcome. The recurrent infection rate was less
frequent in the two-stage revision than in the other in-
terventions during follow-up.
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